CBD and other cannabinoids attach to specific receptors in the body found within what is referred to as the endocannabinoid system. In fact, up until recently, scientists didn’t know that these cannabinoids are actually naturally produced in humans and most animals. Some researchers speculate that an endocannabinoid deficiency may be the cause of many disorders and conditions. When CBD is introduced into the body, it binds to receptor cells called CB1 and CB2 receptors.
CBD MD offers gummies that contain grade-A premium CBD. The cannabinoid extract is full-spectrum, so it contains other cannabinoids such as CBDV and CBG. This product also contains a variety of molecules, terpenes, essential oils, and amino acids to enhance the flavor and the health-promoting benefits. These gummies are 100 percent organic, non-GMO, vegan, and gluten-free. The CBD used to create them has been sourced from organically grown domestic hemp.
While overstimulation of the CB1 receptor may lead to symptoms such as high blood pressure and abnormally high cholesterol levels, CBD is a CB1 antagonist, so it is not likely to cause such issues. Furthermore, the World Health Organization has recently issued a global report on CBD, claiming that it has a good safety profile and minimal adverse public health effects.
When the endocannabinoid system becomes dysregulated, it often becomes overactive and too much fat is being stored, particularly in the intra-abdominal tissue. Cannabidiol is known to regulate the endocannabinoid system as it can restore balance in both directions. Therefore, the study concludes that, along with lifestyle changes cannabis could be a means of fighting obesity.